Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Shares Outstanding (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Shares Outstanding over the past 10 years, most recently at $4.4 million for Q4 2023.

  • For Q4 2023, Shares Outstanding rose 6.05% year-over-year to $4.4 million; the TTM value through Dec 2023 reached $4.4 million, up 6.05%, while the annual FY2023 figure was $4.4 million, 6.05% up from the prior year.
  • Shares Outstanding for Q4 2023 was $4.4 million at Corbus Pharmaceuticals Holdings, roughly flat from $4.4 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $125.2 million in Q3 2021 and troughed at $3.3 million in Q4 2020.
  • A 5-year average of $45.5 million and a median of $34.4 million in 2019 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 72.48% in 2021 and later crashed 96.67% in 2022.
  • Year by year, Shares Outstanding stood at $64.7 million in 2019, then tumbled by 94.91% to $3.3 million in 2020, then rose by 26.72% to $4.2 million in 2021, then increased by 0.04% to $4.2 million in 2022, then grew by 6.05% to $4.4 million in 2023.
  • Business Quant data shows Shares Outstanding for CRBP at $4.4 million in Q4 2023, $4.4 million in Q3 2023, and $4.4 million in Q2 2023.